All News

Found 3,495 articles

• ImmunoGen, Inc. Announces Webcast Of Presentations At Upcoming Investor Conferences

  2/4/2015

• Sorrento Therapeutics, Inc. Announces Retention Of Glen Sato To Provide Strategic Support

  1/30/2015

• ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2015 Financial Results

  1/30/2015

• Sorrento Therapeutics, Inc. Announces Completion Of Enrollment In The Cynviloq™ Registrational TRIBECA™ Study

  1/28/2015

• Goodwin Biotechnology, Inc. And Transporin Announce A Technology Collaboration That Enhances The Ability Of Antibody Drug Conjugates To Target And Deliver Payloads Into Diseased Cells

  1/28/2015

• Pfanstiehl Laboratories Launches New cGMP-produced, Parenteral Grade Maltose For Pharmaceutical Formulations

  1/26/2015

• ImmunoGen, Inc. Announces Conference Call To Discuss Its Second Quarter Fiscal Year 2015 Financial Results

  1/22/2015

• Immune Therapeutics, Inc. Announces Appointment Of New Director And Acceptance Of Election By Director

  1/22/2015

• ChemAxon Ltd. Introduces Biomolecule Toolkit To Extend Their Chemical Intelligence To Biologics

  1/15/2015

• Oxford BioTherapeutics Grants An Exclusive License To Boehringer Ingelheim For Development And Commercialization Of Antibody Products To An Oncology Target

  1/14/2015

• Sorrento Therapeutics, Inc. Provides Status Update On The Cynviloq™ Registrational TRIBECA™ Study

  1/12/2015

• Mersana Therapeutics, Inc., Takeda Pharmaceutical Co. Ltd. Expand Antibody-Drug Pact By $300 Million

  1/12/2015

• Seattle Genetics, Inc. And Bristol-Myers Squibb Company Announce Clinical Collaboration To Evaluate Combination Of Adcetris® (Brentuximab Vedotin) And Opdivo® (Nivolumab) In Hematologic Malignancies

  1/12/2015

• Meditope Biosciences Enhances Leadership Team With New Executive And Board Appointments

  1/7/2015

• Immunomedics, Inc. Appoints Dr. Francois Wilhelm Chief Medical Officer

  1/6/2015

• Conkwest, Sorrento Therapeutics, Inc. And NantWorks Announce Presentation At The 33rd Annual J. P. Morgan Healthcare Conference By Dr. Patrick Soon-Shiong

  1/6/2015

• Compugen Ltd. Discloses Initial Experimental Results For Predicted Antibody Drug Conjugate Targets

  1/5/2015

• Sorrento Therapeutics, Inc. To Present At The 2015 Biotech Showcase And 8th Annual OneMedForum In San Francisco

  1/5/2015

• Assurex Health Locks In $30 Million Financing Round

  12/24/2014

• ImmunoGen, Inc. Reports Roche Has Provided An Update On The MARIANNE Trial

  12/19/2014